GPS Wealth Strategies Group LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 4.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,180 shares of the healthcare conglomerate’s stock after selling 93 shares during the period. GPS Wealth Strategies Group LLC’s holdings in UnitedHealth Group were worth $1,110,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently added to or reduced their stakes in UNH. Norges Bank acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $5,802,231,000. Swedbank AB acquired a new position in shares of UnitedHealth Group in the first quarter valued at approximately $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in UnitedHealth Group by 107.8% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after purchasing an additional 1,196,758 shares during the period. Jennison Associates LLC grew its position in shares of UnitedHealth Group by 49.3% in the 4th quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock valued at $1,904,670,000 after buying an additional 1,195,352 shares during the last quarter. Finally, California Public Employees Retirement System raised its holdings in UnitedHealth Group by 35.9% during the 4th quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock worth $1,627,311,000 after purchasing an additional 815,822 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.
Wall Street Analyst Weigh In
UNH has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research report on Friday, April 19th. HSBC boosted their price objective on UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. JPMorgan Chase & Co. lifted their price target on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. Argus lifted their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Finally, Piper Sandler lifted their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. One equities research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $614.17.
Insider Buying and Selling at UnitedHealth Group
In related news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.
UnitedHealth Group Trading Up 0.9 %
NYSE UNH traded up $5.20 on Wednesday, hitting $579.44. The company’s stock had a trading volume of 2,344,371 shares, compared to its average volume of 4,247,276. The company has a current ratio of 0.88, a quick ratio of 0.85 and a debt-to-equity ratio of 0.67. The firm has a market cap of $533.31 billion, a P/E ratio of 35.37, a PEG ratio of 1.56 and a beta of 0.59. The company’s 50-day simple moving average is $524.56 and its 200 day simple moving average is $505.89. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $591.54.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. During the same period last year, the company posted $6.14 EPS. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. Research analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.45%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Compound Interest and Why It Matters When Investing
- Brinker International’s Price Dip is an Appetizing Entry Point
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 Stocks That Could Beat the September Blues
- Are Penny Stocks a Good Fit for Your Portfolio?
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.